Hierarchical Capillary Coating to Biofunctionlize Drug-Eluting Stent for Improving Endothelium Regeneration

Hierarchical Capillary Coating to Biofunctionlize Drug-Eluting Stent for Improving Endothelium Regeneration

The drug-eluting stent (DES) has become one of the most successful and important medical devices for coronary heart disease, but yet suffers from insufficient endothelial cell (EC) growth and intima repair, eventually leading to treatment failure. Although biomacromolecules such as vascular endothel...

Bibliografiset tiedot
Päätekijät:	Jing Wang, Yunfan Xue, Jun Liu, Mi Hu, He Zhang, Kefeng Ren, Yunbing Wang, Jian Ji
Aineistotyyppi:	Artikkeli
Kieli:	English
Julkaistu:	American Association for the Advancement of Science (AAAS) 2020-01-01
Sarja:	Research
Linkit:	http://dx.doi.org/10.34133/2020/1458090

Samankaltaisia teoksia

Ureteral stent technology: Drug-eluting stents and stent coatings
Tekijä: Luo Yang, et al.
Julkaistu: (2015-10-01)

Coronary Endothelium‐Dependent Vasomotor Function After Drug‐Eluting Stent and Bioresorbable Scaffold Implantation
Tekijä: Josep Gomez‐Lara, et al.
Julkaistu: (2021-11-01)

MODERN COATING TECHNOLOGIES FOR DRUG ELUTING CORONARY STENTS (REVIEW)
Tekijä: E. Y. Zagorulko, et al.
Julkaistu: (2019-01-01)

Development of drug-eluting stent coated with PLGA nanoparticles as drug carriers
Tekijä: Yusuke Tsukada, et al.
Julkaistu: (2013-12-01)

Durable endothelium-mimicking coating for surface bioengineering cardiovascular stents
Tekijä: Qing Ma, et al.
Julkaistu: (2021-12-01)

Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug- Eluting Stents
Tekijä: Negar Faramarzi, et al.
Julkaistu: (2015-10-01)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
Tekijä: Hang Ouyang, et al.
Julkaistu: (2021-04-01)

miR-22 eluting cardiovascular stent based on a self-healable spongy coating inhibits in-stent restenosis
Tekijä: Jing Wang, et al.
Julkaistu: (2021-12-01)

Safety and efficacy of biodegradable polymer-coated biolimus-eluting stents
Tekijä: Walid Maamoun
Julkaistu: (2013-09-01)

A modern generation of drug-eluting stents. Focusing on a sirolimus-eluting stent Calypso
Tekijä: А. Н. Кудряшов, et al.
Julkaistu: (2017-04-01)

Safety and efficacy of biodegradable polymer-coated thin strut sirolimus-eluting stent vs. durable polymer-coated everolimus-eluting stent in patients with acute myocardial infarction
Tekijä: Paweł Gąsior, et al.
Julkaistu: (2018-11-01)

Long-Term Clinical Outcomes of Polymer-Free Sirolimus-Eluting Stent and Polymer-Coated Sirolimus-Eluting Stent in Patients with Type 2 Diabetes
Tekijä: Yang O, et al.
Julkaistu: (2024-11-01)

Biodegradable polymer everolimus-eluting stents versus contemporary drug-eluting stents: a systematic review and meta‑analysis
Tekijä: Juntao Yin, et al.
Julkaistu: (2023-01-01)

Clinical Outcomes of Drug-Eluting versus Bare-Metal In-Stent Restenosis after the Treatment of Drug-Eluting Stent or Drug-Eluting Balloon: A Systematic Review and Meta-Analysis
Tekijä: Yi-Xing Yang, et al.
Julkaistu: (2020-01-01)

Drug-Eluting Stents and Balloons—Materials, Structure Designs, and Coating Techniques: A Review
Tekijä: I. Rykowska, et al.
Julkaistu: (2020-10-01)

Drug Release Analysis and Optimization for Drug-Eluting Stents
Tekijä: Hongxia Li, et al.
Julkaistu: (2013-01-01)

Everolimus-eluting stents versus sirolimus-eluting stents in patients with cardiac allograft vasculopathy
Tekijä: Michał Hawranek, et al.
Julkaistu: (2021-12-01)

Modeling and Analysis of Drug-Eluting Stents With Biodegradable PLGA Coating: Consequences on Intravascular Drug Delivery
Tekijä: Zhu, Xiaoxiang, et al.
Julkaistu: (2017)

Use of drug-coated balloon instead of drug-eluting stent for pediatric cardiac allograft vasculopathy
Tekijä: Masaki Hirose, et al.
Julkaistu: (2023-01-01)

Second Generation Drug-Eluting Stents: A Review of the Everolimus-Eluting Platform
Tekijä: Matthew G. Whitbeck, et al.
Julkaistu: (2013-01-01)

Drug-coated balloons versus drug-eluting stents in patients with in-stent restenosis: An updated meta-analysis with trial sequential analysis
Tekijä: Ahmed Abdelaziz, et al.
Julkaistu: (2024-11-01)

Chiral Separation of Apremilast by Capillary Electrophoresis Using Succinyl-β-Cyclodextrin—Reversal of Enantiomer Elution Order by Cationic Capillary Coating
Tekijä: Zoltán-István Szabó, et al.
Julkaistu: (2023-04-01)

Drug-Coated Balloons versus Everolimus-Eluting Stents in Patients with In-Stent Restenosis: A Pair-Wise Meta-Analysis of Randomized Trials
Tekijä: Nina Peng, et al.
Julkaistu: (2020-01-01)

Studies of biodegradable drug-eluting tracheal stents
Tekijä: Ng, Anthony Herr Cheun
Julkaistu: (2012)

Drug-Eluting Stents: Technical and Clinical Progress
Tekijä: Maciej Koźlik, et al.
Julkaistu: (2023-02-01)

Drug-eluting stents: long-term safety
Tekijä: Yu A Karpov, et al.
Julkaistu: (2009-05-01)

Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V®)
Tekijä: Imad Sheiban, et al.
Julkaistu: (2008-02-01)

Overview of intracoronary brachytherapy for in-stent restenosis of a drug-eluting stent
Tekijä: Sohila Refahi, et al.
Julkaistu: (2019-03-01)

Biodegradable polymer drug-eluting stents versus second-generation drug-eluting stents in patients with and without diabetes mellitus: a single-center study
Tekijä: Xiao-Fang Tang, et al.
Julkaistu: (2018-08-01)

Mathematical modeling and simulation of intravascular drug delivery from drug-eluting stents with biodegradable PLGA coating
Tekijä: Zhu, Xiaoxiang, Ph. D. Massachusetts Institute of Technology
Julkaistu: (2015)

Drug‐Coated Balloon and Drug‐Eluting Stent Safety in Patients With Femoropopliteal and Severe Chronic Kidney Disease
Tekijä: Jonathan Hanna, et al.
Julkaistu: (2023-04-01)

Comparison between drug-coated balloons and drug-eluting stents in very small coronary artery interventions
Tekijä: Cheng-Hsuan Tsai, et al.
Julkaistu: (2022-06-01)

A novel mechanism of inhibiting in-stent restenosis with arsenic trioxide drug-eluting stent: Enhancing contractile phenotype of vascular smooth muscle cells via YAP pathway
Tekijä: Yinping Zhao, et al.
Julkaistu: (2021-02-01)

Stent Fracture after Everolimus-Eluting Stent Implantation
Tekijä: Ali S. Almasood, et al.
Julkaistu: (2011-01-01)

Drug‐Coated Balloons Versus Drug‐Eluting Stents or Plain Old Balloon Angioplasty: A Long‐Term in‐Stent Restenosis Study
Tekijä: Sacharias von Koch, et al.
Julkaistu: (2024-12-01)

Novel drug-eluting stent to reduce fibrosis-induced ureteral stricture
Tekijä: Fong, Timothy Ren Zhong
Julkaistu: (2015)

Introductory Editorial: Drug-Eluting Stents or Drug-Eluting Grafts? Insights from Proteomic Analysis
Tekijä: Spadaccio Cristiano, et al.
Julkaistu: (2016-01-01)

Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
Tekijä: Iraj Jafaripour, et al.
Julkaistu: (2023-05-01)

Use of a sirolimus-eluting stent to treat failure of a nonpolymer release paclitaxel-eluting stent implanted for in-stent restenosis.
Tekijä: Porto, I, et al.
Julkaistu: (2005)

Comparisons of Drug-Eluting Balloon versus Drug-Eluting Stent in the Treatment of Young Patients with Acute Myocardial Infarction
Tekijä: Yi-Xing Yang, et al.
Julkaistu: (2023-01-01)